Literature DB >> 16372318

Novel Lamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease.

Andoni Echaniz-Laguna1, Michel Mohr, Eric Epailly, Ichizo Nishino, Philippe Charron, Pascale Richard, Christophe Guiraud-Chaumeil, Christine Tranchant.   

Abstract

Lysosome-associated membrane protein-2 deficiency (LAMP-2 deficiency), or Danon disease, is a rare X-linked lysosomal disease characterized by cardiomyopathy, vacuolar myopathy, and mental retardation. Less than 20 families with mutations of the Lamp-2 gene have been reported. We describe a family from Sardinia with eight affected patients (4 females and 4 males) and a novel mutation in exon 2 of the Lamp-2 gene (c.102_103delAG). Females developed isolated cardiomyopathy in adulthood, whereas males presented with cardiomyopathy, myopathy, and mental retardation before the age of 20 years. Cardiomyopathy was lethal in three females in their 40s and in three males before the age 20 years. One patient was successfully treated by heart transplantation with more than 5-year follow-up. This study demonstrates that Danon disease is a frequently fatal condition that is potentially treatable with heart transplantation. Muscle Nerve, 2006.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16372318     DOI: 10.1002/mus.20471

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

1.  LAMP-2 deficiency (Danon disease).

Authors:  S Di Mauro; K Tanji; M Hirano
Journal:  Acta Myol       Date:  2007-07

2.  Danon disease. A novel mutation in the LAMP-2 gene and ophthalmic abnormality.

Authors:  J He; Y Wang; T Jiang
Journal:  Herz       Date:  2013-08-18       Impact factor: 1.443

3.  Asymptomatic young man with Danon disease.

Authors:  Jiwon Kim; Parag Parikh; Mohammad Mahboob; James A Arrighi; Michael K Atalay; Ethan J Rowin; Martin S Maron
Journal:  Tex Heart Inst J       Date:  2014-06-01

4.  Late adult-onset of X-linked myopathy with excessive autophagy.

Authors:  Cameron D Crockett; Alessandra Ruggieri; Meena Gujrati; Christopher M Zallek; Nivetha Ramachandran; Berge A Minassian; Steven A Moore
Journal:  Muscle Nerve       Date:  2014-05-17       Impact factor: 3.217

5.  Heterogeneity in a large pedigree with Danon disease: Implications for pathogenesis and management.

Authors:  Jonathan C P Roos; Matthew J Daniels; Elizabeth Morris; Hanna I Hyry; Timothy M Cox
Journal:  Mol Genet Metab       Date:  2017-06-21       Impact factor: 4.797

Review 6.  Infiltrative Cardiomyopathies.

Authors:  David Bejar; Paolo C Colombo; Farhana Latif; Melana Yuzefpolskaya
Journal:  Clin Med Insights Cardiol       Date:  2015-07-08

7.  Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.

Authors:  Barry J Maron; William C Roberts; Michael Arad; Tammy S Haas; Paolo Spirito; Gregory B Wright; Adrian K Almquist; Jeanne M Baffa; J Philip Saul; Carolyn Y Ho; Jonathan Seidman; Christine E Seidman
Journal:  JAMA       Date:  2009-03-25       Impact factor: 56.272

8.  Long-Term Follow-Up of Peripheral Pigmentary Retinopathy in Asian Patients with Danon Disease.

Authors:  Jee Myung Yang; Beom Hee Lee; Gi-Byoung Nam; June-Gone Kim; Joo Yong Lee
Journal:  Genes (Basel)       Date:  2020-11-16       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.